Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· October 31, 2025

ExxonMobil Announces Third-Quarter 2025 Results

View original at finance.yahoo.com
ExxonMobil Announces Third-Quarter 2025 Results Generated strong third-quarter earnings of $7.5 billion and cash flow from operations of $14.8 billion Returned $9.4 billion to shareholders in the quarter and increased fourth-quarter dividend to $1.03 per share Advanced growth ambitions with Permian acreage acquisitions…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Chemical Products high-value product sales achieved record levels in YTD and Q3 2025 since 2019

    80% confidence

  • Lightweight proppant technology improves well recoveries up to 20% in the Permian Basin

    80% confidence

  • Total 2025 share buybacks will reach $20B target

    80% confidence

  • Target of greater than $18B cumulative structural cost savings by 2030

    80% confidence

  • ExxonMobil achieved highest earnings per share in similar oil-price environment compared to last 10 years in Brent $65-75/bbl range

    80% confidence

  • Q3 2025 quarterly refinery throughput is highest on same-site basis

    80% confidence

  • Full-year 2025 capital expenditures will be below the $27-29B guidance range, excluding acquisitions

    80% confidence

  • YTD 2025 global refinery throughput is highest since Exxon-Mobil merger on same-site basis

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com